Cargando…

Early Versus Late Conversion From Immediate to Prolonged-Release Tacrolimus After Renal Transplantation: Clinical Effects and Treatment Costs

INTRODUCTION: Prolonged-release tacrolimus (PR-TAC) was associated with improved renal function after transplantation when compared to immediate-release tacrolimus (IR-TAC) although evidence is still scarce. This study aimed to compare clinical outcomes and treatment costs in patients who converted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendonça, Luís, Diniz, Hugo, Silvano, José, Marques, Sofia, Sampaio, Susana, Pestana, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324909/ https://www.ncbi.nlm.nih.gov/pubmed/30656215 http://dx.doi.org/10.1097/TXD.0000000000000853

Ejemplares similares

Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study
por: Kuypers, Dirk, et al.
Publicado: (2023)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

Safety and Efficacy of Reduced Prolonged-release Tacrolimus Exposure in De Novo Kidney Transplantation: A Randomized, Open-label, Pilot Study in Asia—OPTIMIZE Study
por: Kim, Young Hoon, et al.
Publicado: (2019)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?
por: Haverals, Lien, et al.
Publicado: (2023)

The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function
por: Mahaparn, Irisa, et al.
Publicado: (2023)

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
por: Mo, Hyejin, et al.
Publicado: (2019)

High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients
por: Goodall, Dawn L., et al.
Publicado: (2017)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
por: Pierce, Dana R., et al.
Publicado: (2021)

Identification of Antibiotic Administration as a Potentially Novel Factor Associated With Tacrolimus Trough Variability in Kidney Transplant Recipients: A Preliminary Study
por: Zheng, YuanPu, et al.
Publicado: (2019)

Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

Prolonged Delayed Renal Graft Function Secondary to Venous Hypertension
por: Mishra, Suraj, et al.
Publicado: (2017)

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
por: de Graav, Gretchen N., et al.
Publicado: (2018)

Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016)

Factors Associated With Prolonged Warm Ischemia Time Among Deceased Donor Kidney Transplant Recipients
por: Vinson, Amanda J., et al.
Publicado: (2018)

One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants
por: Noguchi, Hiroshi, et al.
Publicado: (2019)

Assessing Predictors of Early and Late Hospital Readmission After Kidney Transplantation
por: Hogan, Julien, et al.
Publicado: (2019)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Significant Improvement in Rat Kidney Cold Storage Using UW Organ Preservation Solution Supplemented With the Immediate-Acting PrC-210 Free Radical Scavenger
por: Verhoven, Bret M., et al.
Publicado: (2020)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Prolonged Normothermic Ex Vivo Kidney Perfusion Is Superior to Cold Nonoxygenated and Oxygenated Machine Perfusion for the Preservation of DCD Porcine Kidney Grafts
por: Mazilescu, Laura I., et al.
Publicado: (2021)

Prolonged Survival and Preserved Renal Graft Function in a Kidney Transplant Patient With Advanced Urothelial Carcinoma Using an Immune Checkpoint Inhibitor: A Case Report
por: Mavichak, Weerawaroon, et al.
Publicado: (2023)

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial
por: Johnson, Aileen C., et al.
Publicado: (2023)

The Association Between Kidney Donor Profile Index and 1-y Graft Function
por: Foresto, Renato Demarchi, et al.
Publicado: (2023)

Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation
por: Butiu, Maria, et al.
Publicado: (2022)

Economic Evaluation of Screening for Polyomavirus Infection in Kidney Transplant Recipients: A Cost-Utility Analysis
por: Wong, Germaine, et al.
Publicado: (2022)

Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting
por: Hedley, James A., et al.
Publicado: (2023)

Late Reoccurrence of Collapsing FSGS After Transplantation of a Living-Related Kidney Bearing APOL 1 Risk Variants Without Disease Evident in Donor Supports the Second Hit Hypothesis
por: Kalil, Roberto S., et al.
Publicado: (2017)

Randomized Trial of Machine Perfusion Versus Cold Storage in Recipients of Deceased Donor Kidney Transplants With High Incidence of Delayed Graft Function
por: Tedesco-Silva, Helio, et al.
Publicado: (2017)

Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection
por: Clotet-Freixas, Sergi, et al.
Publicado: (2021)

Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
por: González-Corvillo, Carmen, et al.
Publicado: (2019)

A Randomized Controlled Trial of a Mobile Medical App for Kidney Transplant Recipients: Effect on Use of Sun Protection
por: Robinson, June K., et al.
Publicado: (2015)

The World's Youngest Cadaveric Kidney Transplant: Medical, Surgical and Ethical Issues
por: Daar, Abdallah S., et al.
Publicado: (2016)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy
por: Luttropp, Karin, et al.
Publicado: (2016)

Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient
por: Inui, Masashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gl897vu07vgh7hjc5f2aa60kbj